Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Role of Tyrosine Kinase Lyn and Cleaved Form by Caspases in Psoriasis [NA]
This clinical trial update discusses the role of Lyn tyrosine kinase and caspase-cleaved forms in psoriasis, with the study status listed as…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Pilot Study on the Efficacy of 2% Cholesterol Cream in Preventing Transepidermal Water Loss and Clinical Symptoms in Mild to Moderate Atopic Dermatitis [NA]
A pilot study sponsored by the Institute of Dermatology in Thailand is evaluating whether 2% cholesterol cream can prevent transepidermal wa…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Moderate-to-severe Atopic Dermatitis [Phase 2]
A Phase 2 study evaluating the efficacy and safety of AK139 in adults with moderate-to-severe atopic dermatitis. The trial is currently NOT_…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
Clinical trial update notes ongoing sample collection from participants with acne, atopic dermatitis, chronic hand eczema, hidradenitis supp…
-
CLINICAL_TRIALS other · 2026-03-27Clinical Trial Update: A Study of Barzolvolimab in Patients With Atopic Dermatitis [Phase 2]
This entry covers a Phase 2 clinical trial of Barzolvolimab for atopic dermatitis. The study is currently active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis [Phase 2]
A Phase 2 long-term safety and efficacy study evaluating APG777 for atopic dermatitis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis [Phase 3]
Amgen reports completion of a Phase 3 trial evaluating self-administered rocatinlimab in adolescents and adults with moderate-to-severe atop…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis [Phase 2]
Phase 2 trial update for ATI-045 in moderate-to-severe atopic dermatitis. The study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis [Phase 1]
Phase 1 active-comparator safety study evaluating the combination of APG777 and APG990 for moderate-to-severe atopic dermatitis; the trial i…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease [Phase 4]
A Phase 4 clinical trial update notes a study on how salt intake affects sodium in the skin and inflammatory skin diseases, focusing on atop…
-
EMA approval · 2026-03-20EMA Authorised: Ebglyss (Lebrikizumab) — Almirall, S.A.
EMA authorised Ebglyss (Lebrikizumab) for atopic dermatitis, with Almirall, S.A. as the marketing authorisation holder. Decision date: 14 Ja…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
This document summarizes an ongoing longitudinal observational study of patients undergoing therapy for IMISC (NCT03661866) across several i…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of tralokinumab plus topical corticosteroids in children and infants with moderate-to-sev…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2) [Phase 3]
This Phase 3 trial (COAST 2) evaluated subcutaneous amlitelimab monotherapy versus placebo in participants aged 12 and older with moderate-t…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Maternal Key Nutritional Factors and Offspring's Atopic Dermatitis (MKNFOAD)
A completed clinical trial update examining how maternal key nutritional factors influence the risk of offspring developing atopic dermatiti…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.
This document provides a clinical trial update for Pfizer's CIBINQO (abrocitinib) in people with atopic dermatitis, noting the study is curr…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic Dermatitis [Phase 3]
A Phase 3 clinical trial evaluating MG-K10 for Atopic Dermatitis has been announced, but the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Dynamic Blood Inflammatory Profile in Atopic Dermatitis Patients (ADAMUNE) [NA]
A clinical trial update for the ADAMUNE study investigating dynamic blood inflammatory profiles in adults with atopic dermatitis; the trial …
-
CLINICAL_TRIALS other · 2026-03-18Clinical Trial Update: A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology [NA]
This is a randomized controlled trial assessing ePROM-guided flexible scheduling in dermatology, targeting eczema (atopic dermatitis), urtic…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: The Impact of Dietary Salt on the Severity of Eczema [Phase 4]
A Phase 4 clinical trial is exploring whether dietary salt intake influences the severity of atopic dermatitis, with the study currently NOT…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AK120 in Subjects With Moderate to Severe Atopic Dermatitis [Phase 2]
This clinical trial update notes the completion of a Phase 2 study evaluating the efficacy and safety of AK120 in adults with moderate to se…
-
FDA label_change · 2026-03-16FDA Approved: DESOXIMETASONE — Supplemental Application (Saptalis Pharmaceuticals, LLC.)
FDA approved a supplemental application for desoximetasone (Saptalis Pharmaceuticals, LLC.), resulting in updated labeling for this topical …
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Clinical Evaluation of a Soothing Moisturizing Lotion in Individuals With Atopic Eczema [NA]
This clinical trial update concerns a soothing moisturizing lotion being evaluated for atopic dermatitis (eczema). Recruitment is ongoing, w…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
This clinical trial update reports real-world experience with nemolizumab for moderate-to-severe atopic dermatitis in adolescents and adults…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: IDA (Immunothérapie de la Dermatite Atopique) Adult - Immunotherapy in Atopic Dermatitis [NA]
This update notes the completion of a clinical study of IDA immunotherapy for adults with atopic dermatitis. The trial was sponsored by INSE…